The role of visfatin (PBEF/Nampt) in pregnancy complications

被引:31
作者
Pavlova, Tereza [1 ]
Novak, Jan [1 ]
Bienertova-Vasku, Julie [1 ,2 ]
机构
[1] Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno 62500, Czech Republic
[2] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno 65653, Czech Republic
关键词
Preterm labor; Pre-eclampsia; Gestational diabetes mellitus; Maternal plasma; Sirtuins; Visfatin; COLONY-ENHANCING FACTOR; GESTATIONAL DIABETES-MELLITUS; REGULATES INSULIN-SECRETION; AMNIOTIC EPITHELIAL-CELLS; FETAL MEMBRANE DISTENSION; ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; MATERNAL PLASMA VISFATIN; SERUM-LEVELS; PRETERM PARTURITION;
D O I
10.1016/j.jri.2015.09.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Visfatin (PBEF/Nampt) is an adipocytokine that exerts pleiotropic effects within the human body, particularly affecting its metabolism and immunity. Visfatin was originally identified as being secreted by peripheral blood lymphocytes acting as a pre-B-cell colony-enhancing factor (PBEF). However, it was subsequently reported to be expressed in almost every tissue of the human body, with visceral fat deposits being the main source of visfatin. In addition to its secreted form, visfatin may also be found intracellularly where it functions as a nicotinamide phosphoribosyltransferase (Nampt). Visfatin maternal plasma concentrations increase during pregnancy, suggesting its important role in this complicated process. Alterations in visfatin level also take place in patients during pregnancy complications. This review focuses on the ones that most commonly occur in connection with visfatin: preterm labor, pre-eclampsia and gestational diabetes mellitus. The review aims to provide a better understanding of the role of visfatin during pregnancy and the causes of its alteration in maternal plasma, highlighting the potential use of visfatin as a diagnostic marker of pregnancy complications in the future. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:102 / 110
页数:9
相关论文
共 91 条
[21]   Maternal serum visfatin at 11-13 weeks' gestation in preeclampsia [J].
Ferreira, A. F. A. ;
Rezende, J. C. ;
Oliveira, R. de Cassia C. ;
Oliveira, C. ;
Akolekar, R. ;
Nicolaides, K. H. .
JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (04) :261-264
[22]   Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome [J].
Filippatos, T. D. ;
Derdemezis, C. S. ;
Kiortsis, D. N. ;
Tselepis, A. D. ;
Elisaf, M. S. .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2007, 30 (04) :323-326
[23]   RETRACTED: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007) [J].
Fukuhara, A ;
Matsuda, M ;
Nishizawa, M ;
Segawa, K ;
Tanaka, M ;
Kishimoto, K ;
Matsuki, Y ;
Murakami, M ;
Ichisaka, T ;
Murakami, H ;
Watanabe, E ;
Takagi, T ;
Akiyoshi, M ;
Ohtsubo, T ;
Kihara, S ;
Yamashita, S ;
Makishima, M ;
Funahashi, T ;
Yamanaka, S ;
Hiramatsu, R ;
Matsuzawa, Y ;
Shimomura, I .
SCIENCE, 2005, 307 (5708) :426-430
[24]   Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retraction of vol 307, pg 426, 2005) [J].
Fukuhara, Atsunori ;
Matsuda, Morihiro ;
Nishizawa, Masako ;
Segawa, Katsumori ;
Tanaka, Masaki ;
Kishimoto, Kae ;
Matsuki, Yasushi ;
Murakami, Mirei ;
Ichisaka, Tomoko ;
Murakami, Hiroko ;
Watanabe, Eijiro ;
Takagi, Toshiyuki ;
Akiyoshi, Megumi ;
Ohtsubo, Tsuguteru ;
Kihara, Shinji ;
Yamashita, Shizuya ;
Makishima, Makoto ;
Funahashi, Tohru ;
Yamanaka, Shinya ;
Hiramatsu, Ryuji ;
Matsuzawa, Yuji ;
Shimomura, Iichiro .
SCIENCE, 2007, 318 (5850) :565-565
[25]   The release of the adipocytokine visfatin is regulated by glucose and insulin [J].
Haider, D. G. ;
Schaller, G. ;
Kapiotis, S. ;
Maier, C. ;
Luger, A. ;
Wolzt, M. .
DIABETOLOGIA, 2006, 49 (08) :1909-1914
[26]   Visfatin response to glucose is reduced in women with gestational diabetes mellitus [J].
Haider, Dominik G. ;
Handisurya, Ammon ;
Storka, Angela ;
Vojtassakova, Elena ;
Luger, Anton ;
Pacini, Giovanni ;
Tura, Andrea ;
Wolzt, Michael ;
Kautzky-Willer, Alexandra .
DIABETES CARE, 2007, 30 (07) :1889-1891
[27]   The adipokine visfatin is markedly elevated in obese children [J].
Haider, Dominik G. ;
Holzer, Gregor ;
Schaller, Georg ;
Weghuber, Daniel ;
Widhahn, Kurt ;
Wagner, Oswald ;
Kapiotis, Stylianos ;
Wolzt, Michael .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 43 (04) :548-549
[28]   Serum visfatin levels in late pregnancy and pre-eclampsia [J].
Hu, Wensheng ;
Wang, Zhengping ;
Wang, Hanzhi ;
Huang, Hefeng ;
Dong, Minyue .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2008, 87 (04) :413-418
[29]   Visfatin: A new adipokine [J].
Hug, C ;
Lodish, HF .
SCIENCE, 2005, 307 (5708) :366-367
[30]   Dissecting systemic control of metabolism and aging in the NAD World: The importance of SIRT1 and NAMPT-mediated NAD biosynthesis [J].
Imai, Shin-ichiro .
FEBS LETTERS, 2011, 585 (11) :1657-1662